HUTCHMED (CHINA) LIMITED - AMERICAN DEPOSITARY SHA
18.76
01-May-24 14:59:59
15 minutes delayed
Stocks
+0.25
+1.35%
Today's range
18.31 - 18.96
ISIN
N/A
Source
NASDAQ
-
HUTCHMED Reports 2022 Full Year Results and Provides Business Updates
28 Feb 2023 02:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED to Announce 2022 Final Results
31 Jan 2023 02:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
23 Jan 2023 02:00:55 By Nasdaq GlobeNewswire
-
18 Jan 2023 08:30:00 By Nasdaq GlobeNewswire
-
03 Jan 2023 02:30:00 By Nasdaq GlobeNewswire
-
19 Dec 2022 04:00:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals
14 Nov 2022 18:00:00 By Nasdaq GlobeNewswire
-
13 Nov 2022 18:00:00 By Nasdaq GlobeNewswire
-
27 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
10 Oct 2022 03:30:00 By Nasdaq GlobeNewswire
-
07 Sep 2022 17:30:00 By Nasdaq GlobeNewswire
-
23 Aug 2022 03:30:00 By Nasdaq GlobeNewswire
-
Inmagene and HUTCHMED Announce First Participant in Global Phase I Trial of IMG-004
09 Aug 2022 03:30:00 By Nasdaq GlobeNewswire
-
07 Aug 2022 19:00:00 By Nasdaq GlobeNewswire
-
15 Jul 2022 03:30:00 By Nasdaq GlobeNewswire
-
12 Jul 2022 19:00:00 By Nasdaq GlobeNewswire
-
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007
05 Jul 2022 23:40:34 By Nasdaq GlobeNewswire
-
HUTCHMED to Announce 2022 Half-Year Financial Results
27 Jun 2022 03:30:00 By Nasdaq GlobeNewswire
-
HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China
01 Jun 2022 03:33:07 By Nasdaq GlobeNewswire